For patient-related information about the ICT-107 cancer vaccine phase II program please:

  1. Access the ICT-107 FAQ (Frequently Asked Questions) click here.
  2. Send an email message to clintrials@imuc.com, including your contact information and your specific questions.
  3. Call 818 264 2315 and leave a brief message, including your contact information and questions.

Someone knowledgeable about the ICT-107 clinical program will respond to your inquiry shortly.

PRESS RELEASES

Tuesday, March 03, 2015
ImmunoCellular Therapeutics to Present at ROTH Conference on March 10th read more ...
Monday, March 02, 2015
ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Con read more ...
Wednesday, February 18, 2015
ImmunoCellular Therapeutics Strengthens Executive Management Team with Appointment of Dr. Steven Swa read more ...
Thursday, February 12, 2015
ImmunoCellular Therapeutics, Ltd. Announces Pricing of a Public Offering of Common Stock and Warrant read more ...

EVENTS

Tuesday, March 03, 2015
ImmunoCellular Therapeutics webcast at the 27th Annual ROTH Confere
Monday, March 02, 2015
March 12 2015 Business Update Conference Call and Webcast
Friday, November 14, 2014
ImmunoCellular to Host Conference Call on Tuesday, November 18th
 
Copyright 2015 by Immunocellular Therapeutics, Ltd.
All Rights Reserved